Aria F. Olumi

This study shows SRD5A2 promotes prostate growth via WNT5A-LEF1-IGF1 signaling in BPH, independent of androgen levels.

This study shows that obesity-induced stem-like prostate remodeling reduces 5α-reductase inhibitor effectiveness in BPH, and combining weight control with therapy improves outcomes.

This study identifies differential expression and functional roles of ectonucleotidases and purinergic receptors in mouse prostate cells, revealing their involvement in smooth muscle contraction and potential relevance to prostate diseases.

This study identifies molecular subgroups of BPH and suggests mTOR inhibitors as a potential therapy for specific subtypes.